NEW YORK, Jan 8 -   After protein chip maker Ciphergen announced its fourth quarter revenues would be 10 to 15 percent lower than it had originally expected, the company’s stock took a dive in Monday trading, closing 30 percent lower than its opening price.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.